MedPath

Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.

Not Applicable
Withdrawn
Conditions
Head and Neck Neoplasia
Interventions
Procedure: Ultra-sound guided radio-frequency ablation
Registration Number
NCT00381225
Lead Sponsor
Johns Hopkins University
Brief Summary

To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the management of head and neck neoplasia.

Detailed Description

The study evaluates the feasibility of radio-frequency ablation in the management of head and neck neoplasia.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Patients with head and neck neoplasia.
Exclusion Criteria
  • When the patient does not meet the inclusion criteria.
  • When the patient has a contra-indication of surgery or anesthesia.
  • If the patient refuses involvement in the study.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Ultra-sound guided radio-frequency ablationUltra-sound guided radio-frequency ablation-
Primary Outcome Measures
NameTimeMethod
Technical successLength of the procedure, up to 1 hour

Technical success is defined as the ability to successfully enter the thyroid nodule via ultrasound guidance and apply the RFA. Assessed via surgeon self report

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Hopkins University School of Medicine, Department of Otolaryngology-Head and Neck Surgery

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath